Abdullah Muhammed Abdulrahem
Papers
1
Total Citations
2
H-Index
1
About
Dr. Abdullah Muhammed Abdulrahem is a pioneering surgical oncologist whose work centers on advancing minimally invasive approaches for peritoneal surface malignancies. His primary research focuses on cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), a complex, life-extending treatment for peritoneal metastasis. Dr. Abdulrahem’s major contribution is demonstrating the feasibility and safety of robotic and laparoscopic CRS/HIPEC, challenging the traditional open-surgery paradigm. His landmark 2024 multicenter study from Saudi Arabia, which has garnered early citations, provides critical evidence that these less invasive techniques can achieve comparable oncologic outcomes while potentially reducing recovery times and complications. This work positions him as a key figure in the global shift toward precision, minimally invasive surgical oncology. By leading a collaborative, multi-institutional effort, Dr. Abdulrahem has not only advanced surgical technique but also established a framework for future research in the Middle East. His ongoing impact lies in broadening access to aggressive, yet patient-friendly, treatments for peritoneal cancer, making him a notable voice in the field.
Research Focus
Key Achievements
Top Papers
- 1